#Immunofluorescence Assay Market Size

[market-insider]

Immunofluorescence Assay Market Size and Growth Potential: An In-Depth Analysis

The global immunofluorescence assay market size is anticipated to reach USD 4.95 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to reach at a CAGR of 5.29% from 2023 to 2030. Immunofluorescence is a traditional technique used for getting insight into cellular processes and structures using microscopy. For instance, specific proteins can be assessed for their location and expression. Increasing prevalence of chronic and infectious diseases, significant applications of immunofluorescence assay (IFA) in several areas and technological advancements in techniques and associated instruments are key factors driving the market growth.

Gain deeper insights on the market and receive your free copy with TOC now @: Immunofluorescence Assay Market Report

The immunofluorescence assay market is anticipated to witness rapid growth, owing to the technological advances and launch of novel instruments. For instance, in November 2020, CTK Biotech, Inc. introduced RaFIA immunofluorescence immunoassay system to meet the rising demand for quantitative rapid tests. The system is user friendly, offers a high level of sensitivity and a broad working range. In addition, in March 2021, Euroimmum introduced an automated immunofluorescence microscope EPML (EUROPattern Microscope Live). The instrument comprises of 20x high camera resolution and captures the image within 2 seconds. Such developments are increasing the efficiency and adoption of the technique, thereby fueling the market growth.

The chronic diseases such as Alzheimer’s, HIV, and Chron’s disease have increased globally over the last few decades. For instance, according to CDC, in 2020, 5.8 million individuals in America were living with Alzheimer’s disease. According to WHO, 38.4 million individuals were living with HIV globally by the end of 2021. Hence, the growing awareness and increasing demand for the detection and cure of several chronic and infectious diseases are some of the driving factors for the market growth.

[ashishjadhav23]

Immunofluorescence Assay Market Partnering Deals of Key Players 2024 – 2031

The Insight Partners recently announced the release of the market research titled Immunofluorescence Assay Market Outlook to 2031 | Share, Size, and Growth. The report is a stop solution for companies operating in the Immunofluorescence Assay market. The report involves details on key segments, market players, precise market revenue statistics, and a roadmap that assists companies in advancing their offerings and preparing for the upcoming decade. Listing out the opportunities in the market, this report intends to prepare businesses for the market dynamics in an estimated period.

Is Investing in the Market Research Worth It?

Some businesses are just lucky to manage their performance without opting for market research, but these incidences are rare. Having information on longer sample sizes helps companies to eliminate bias and assumptions. As a result, entrepreneurs can make better decisions from the outset. Immunofluorescence Assay Market report allows business to reduce their risks by offering a closer picture of consumer behavior, competition landscape, leading tactics, and risk management.

A trusted market researcher can guide you to not only avoid pitfalls but also help you devise production, marketing, and distribution tactics. With the right research methodologies, The Insight Partners is helping brands unlock revenue opportunities in the Immunofluorescence Assay market.

If your business falls under any of these categories – Manufacturer, Supplier, Retailer, or Distributor, this syndicated Immunofluorescence Assay market research has all that you need.

What are Key Offerings Under this Immunofluorescence Assay Market Research?

Global Immunofluorescence Assay market summary, current and future Immunofluorescence Assay market size

Market Competition in Terms of Key Market Players, their Revenue, and their Share

Economic Impact on the Industry

Production, Revenue (value), Price Trend

Cost Investigation and Consumer Insights

Industrial Chain, Raw Material Sourcing Strategy, and Downstream Buyers

Production, Revenue (Value) by Geographical Segmentation

Marketing Strategy Comprehension, Distributors and Traders

Global Immunofluorescence Assay Market Forecast

Study on Market Research Factors

Who are the Major Market Players in the Immunofluorescence Assay Market?

Immunofluorescence Assay market is all set to accommodate more companies and is foreseen to intensify market competition in coming years. Companies focus on consistent new launches and regional expansion can be outlined as dominant tactics. Immunofluorescence Assay market giants have widespread reach which has favored them with a wide consumer base and subsequently increased their Immunofluorescence Assay market share.

Report Attributes

Details

Segmental Coverage

Type

Micro Immunofluorescence

Indirect Immunofluorescence

Direct Immunofluorescence

Product

Antibodies

Kits & Reagents

Labeling Dyes

Instruments

Disease

Cancer

Infectious Diseases

Cardiovascular Diseases

Autoimmune Diseases

Others

End User and Geography

Pharmaceutical & Biotechnology Companies

Academic & Research Institute

Hospitals & Diagnostic Centers

Contract Research Organizations Geography

and Geography

Regional and Country Coverage

North America (US, Canada, Mexico)

Europe (UK, Germany, France, Russia, Italy, Rest of Europe)

Asia Pacific (China, India, Japan, Australia, Rest of APAC)

South / South & Central America (Brazil, Argentina, Rest of South/South & Central America)

Middle East & Africa (South Africa, Saudi Arabia, UAE, Rest of MEA)

Market Leaders and Key Company Profiles

Thermo Fisher Scientific Inc.

Abcam plc.

Bio-Rad Laboratories, Inc.

PerkinElmer Inc.

Merck KGaA

BD

Agilent Technologies, Inc.

Enzo Life Sciences, Inc.

Sino Biological Inc.

Danaher

Cell Signaling Technology, Inc.

Bio SB

?

Other key companies 

What are Perks for Buyers?

The research will guide you in decisions and technology trends to adopt in the projected period.

Take effective Immunofluorescence Assay market growth decisions and stay ahead of competitors

Improve product/services and marketing strategies.

Unlock suitable market entry tactics and ways to sustain in the market

Knowing market players can help you in planning future mergers and acquisitions

Visual representation of data by our team makes it easier to interpret and present the data further to investors, and your other stakeholders.

Do We Offer Customized Insights? Yes, We Do!

The The Insight Partners offer customized insights based on the client’s requirements. The following are some customizations our clients frequently ask for:

The Immunofluorescence Assay market report can be customized based on specific regions/countries as per the intention of the business

The report production was facilitated as per the need and following the expected time frame

Insights and chapters tailored as per your requirements.

Depending on the preferences we may also accommodate changes in the current scope.

[blog-site-for-market-research]

Understanding Market Dynamics in the Autoimmune Disease Diagnostics Market Industry

Market Overview –

The size of the market for autoimmune disease diagnostics was estimated at USD 4.9 billion in 2022 and is expected to increase at a compound yearly growth rate (CAGR) of 6.7% from USD 5.23 billion in 2023 to USD 8.78 billion by 2032.

The autoimmune disease diagnostics market is witnessing growth driven by advancements in the diagnosis of lupus and other autoimmune conditions. With increasing awareness and understanding of these diseases, there's a rising demand for accurate and efficient diagnostic tools. Innovations in biomarker testing and imaging techniques are enhancing early detection and personalized treatment strategies, driving market expansion.

The autoimmune disease diagnostics market focuses on providing tools and tests for diagnosing autoimmune diseases, a group of conditions where the immune system attacks healthy cells and tissues. These diseases can affect various organs and systems in the body, leading to chronic inflammation, tissue damage, and functional impairment.

Market growth is driven by the increasing prevalence of autoimmune diseases worldwide, attributed to factors such as genetic predisposition, environmental triggers, and lifestyle factors. With millions of people affected by autoimmune diseases, there is a growing demand for accurate and timely diagnostic tests to facilitate early intervention and improve patient outcomes.

Technological advancements and innovations in autoimmune disease diagnostics are shaping the market, offering new biomarkers, imaging techniques, and molecular assays to enhance diagnostic accuracy and precision. From serological tests and genetic testing to advanced imaging modalities and point-of-care devices, these advancements enable healthcare providers to diagnose autoimmune diseases more effectively and tailor treatment strategies to individual patient needs.

Moreover, the growing recognition of the importance of early detection and personalized medicine is driving market growth, as healthcare systems prioritize preventive healthcare and precision diagnostics to improve patient care and reduce healthcare costs.

However, challenges such as variability in disease presentation, overlapping symptoms, and limited awareness among healthcare providers pose obstacles to market growth. Addressing these challenges requires greater education and training for healthcare professionals, improved access to diagnostic tools and resources, and collaboration between industry stakeholders to develop standardized diagnostic protocols and guidelines.

Segmentation –

The global autoimmune disease diagnostics market has been segmented on the basis of disease type, test type, and end-user.

The market, by disease type, has been classified as systemic autoimmune disease, and localized autoimmune disease. The systemic autoimmune disease segment has been further classified into psoriasis, multiple sclerosis, rheumatoid arthritis, systemic lupus erythematosus (SLE), and others. Localized autoimmune disease segment has been divided into inflammatory bowel disease, thyroid, type 1 diabetes, and others.

On the basis of test type, the market has been segregated into  western blotting, enzyme-linked immunosorbent assay (ELISA), double immune diffusion, dot blot, counter immune-electrophoresis, line blot, immunofluorescence assays (IFA), multiplex immunoassay, agglutination, and others.

The end-user segment has been divided into, has been segmented into hospitals, diagnostics centers, research laboratories, and others

Regional Analysis –

The autoimmune disease diagnostics market varies regionally due to differences in disease prevalence, diagnostic infrastructure, and healthcare expenditure. Developed regions like North America and Europe have a higher prevalence of autoimmune diseases and well-established diagnostic capabilities, leading to a robust market for autoimmune disease diagnostics. In contrast, developing regions face challenges such as limited access to specialized testing facilities and lower awareness of autoimmune diseases, resulting in underdiagnosis and undertreatment.

Moreover, variations in regulatory frameworks and reimbursement policies influence market dynamics across different regions. As the burden of autoimmune diseases continues to rise globally, there is a growing need for affordable and accessible diagnostic solutions, particularly in underserved regions. Collaborative efforts between healthcare stakeholders and diagnostic companies are essential to address regional disparities and improve patient outcomes in the autoimmune disease diagnostics market.

Key Players –

Autoimmune disease diagnostics companies include Siemens Healthcare Private Limited, bioMérieux SA, Bio-rad Laboratories, Beckman Coulter, AstraZeneca, EUROIMMUN AG, Hoffmann-la Roche, Inova Diagnostics, Myriad Genetics, Thermo Fisher Scientific, Trinity Biotech Plc., and Hemagen Diagnostics.

Related Reports –

Urinalysis Test

Celiac Disease Treatment

Healthcare Enterprise Software

Amniotic Membrane

For more information visit at MarketResearchFuture

[tip-research24]

Immunofluorescence Assay Market Size, Share, Comprehensive Analysis, Opportunity Assessment by 2031

The Insight Partners has unveiled its latest market research offering, providing a comprehensive analysis of the “ Immunofluorescence Assay Market Forecast” and growth potential. The report, titled “Immunofluorescence Assay Market Size, Share and Trends | 2030” is a culmination of extensive research and expert insights, offering valuable information for both dominant market players and bootstrapped startups aiming to make informed decisions in the “Immunofluorescence Assay Market”.

We are committed to delivering high-quality market research that empowers businesses to thrive in a rapidly evolving market environment. Our research analysts have used top-down, bottom-up, primary, and secondary research approaches to evaluate and approve the market conclusions. The insights presented in the “Immunofluorescence Assay Market Report” are designed to assist companies in formulating effective strategies for growth and sustainability.

The report offers statistical data such as market share, size, and CAGR estimates. A thorough “Immunofluorescence Assay Market Analysis” revealed the key companies operating are Thermo Fisher Scientific Inc., Abcam plc., Bio-Rad Laboratories, Inc., PerkinElmer Inc., Merck KGaA, BD, Agilent Technologies, Inc., Enzo Life Sciences, Inc., Sino Biological Inc., Danaher1, Cell Signaling Technology, Inc.1, Bio SB, ? . This market research is based on data and facts collected from authoritative sources.

Key Highlights of the Report

Uncovering the dynamic forces driving the “Immunofluorescence Assay Market Growth”, such as economic factors, technological advancements, and regulatory influences.

Understanding consumer behavior by delving into consumer preferences, purchasing patterns, and factors influencing buying decisions.

Breaking down the Immunofluorescence Assay market into key segments, providing a detailed examination of each segment's “Immunofluorescence Assay market share”, growth potential, and strategic considerations.

Analyzing regional trends and variations, offering businesses a nuanced understanding of market dynamics in different geographical areas.

Analysis of key players in the market, including their market share, product portfolios, and key strategies.

By combining a strategic approach, advanced methodologies, and a commitment to quality, we strive to set the standard for excellence in market research. Our dedication to innovation ensures that our clients receive insights that drive success in the ever-evolving landscape of any market.

What contributes to the authenticity of this research?

Comprehensive summary of present Immunofluorescence Assay market condition.

Accurate estimations on market revenue forecasts and CAGR to rationalize resources.

Regional reporting to uncover new markets for business

Competition analysis aims to help corporations in a modest edge.

Facts-based crystal-clear insights for business success.

The research is modified as per business necessities.

Access to PDF, and PPT formats of this research.

Why Choose Customization with The Insight Partners?

Relevance and Precision: Receive insights directly relevant to your operations, enhancing decision-making effectiveness.

Cost-Efficiency: Pay for insights that align with your objectives, optimizing your investment.

Strategic Alignment: Seamlessly integrate findings with existing strategies for enhanced organizational success.

Consumer Trends and Insights

The report captures the latest “Immunofluorescence Assay market trends”, emerging technologies, and industry shifts, empowering clients to stay ahead of the curve. This section will present insights on brand promotion, product marketing, and target consumers.

Market Segmentation

This market research is based on key segments such as products, end-use industries, and regions. We intend to keep our clients informed about the latest trends in the market, and potential revenue streams for the forecast period.On the Basis of Type this market is categorized further into-

Micro Immunofluorescence

Indirect Immunofluorescence

Direct Immunofluorescence

On the Basis of Product this market is categorized further into-

Antibodies

Kits & Reagents

Labeling Dyes

Instruments

On the Basis of Disease this market is categorized further into-

Cancer

Infectious Diseases

Cardiovascular Diseases

Autoimmune Diseases

Others

On the Basis of End User and Geography this market is categorized further into-

Pharmaceutical & Biotechnology Companies

Academic & Research Institute

Hospitals & Diagnostic Centers

Contract Research Organizations Geography

Key regions Immunofluorescence Assay Market Research Report:

North America (U.S., Canada, Mexico)

Europe (U.K., France, Germany, Spain, Italy, Central & Eastern Europe, CIS)

Asia Pacific (China, Japan, South Korea, ASEAN, India, Rest of Asia Pacific)

Latin America (Brazil, Rest of Latin America)

The Middle East and Africa (Turkey, GCC, Rest of the Middle East and Africa)

Rest of the World

[themarketinsights]

Rapid Influenza Diagnostic Test Market to See Huge Growth by 2028

Latest released the research study on Global Rapid Influenza Diagnostic Test Market, offers a detailed overview of the factors influencing the global business scope. Rapid Influenza Diagnostic Test Market research report shows the latest market insights, current situation analysis with upcoming trends and breakdown of the products and services. The report provides key statistics on the market status, size, share, growth factors of the Rapid Influenza Diagnostic Test The study covers emerging player’s data, including: competitive landscape, sales, revenue and global market share of top manufacturers are Thermo Fisher Scientific (United States), F. Hoffmann-La Roche AG (Switzerland), Abbott Laboratories (United States), Quidel Corporation (United States), Becton, Dickinson and Company (United States), DiaSorin (Italy), SA Scientific Ltd. (United States), Meridian Bioscience, Inc. (United States), Analytik Jena AG (Germany), Luminex Corporation (United States),

Free Sample Report + All Related Graphs & Charts @: https://www.advancemarketanalytics.com/sample-report/83627-global-rapid-influenza-diagnostic-test-market

Rapid Influenza Diagnostic Test Market Definition:

A rapid influenza diagnostic test helps to determine whether a person has a current influenza infection by detecting the influenza viral nucleoprotein antigen. Some of the major advantages of rapid influenza diagnostic tests are RIDTs are approved for office or bedside use, produce a quick result in 15 minutes or less, simple to perform, among others. There are various factors which influence the accuracy of RIDTs such as clinical signs and symptoms consistent with influenza, the prevalence of influenza activity in the population tested, the accuracy of the test compared to a reference test, among others.

Market Trend:

Technology Advancement in Rapid Influenza Diagnostic Test

Market Drivers:

Growing Usage of RFID in Various Application

High Invested Research as well as Development Regarding Rapid Influenza Diagnostic Tests

Increasing Number of Influenza Patients across the world

 

Market Opportunities:

Growing Demand from Emerging Market such as China, India, Brazil, among others

The Global Rapid Influenza Diagnostic Test Market segments and Market Data Break Down are illuminated below:

by Type (Digital RIDTs, Conventional RIDT), Application (Hospitals & Clinics, Laboratories, Other), Test (Point-of-Care test, Nucleic Acid Test, Immunofluorescence Assays, Others)

Region Included are: North America, Europe, Asia Pacific, Oceania, South America, Middle East & Africa

Country Level Break-Up: United States, Canada, Mexico, Brazil, Argentina, Colombia, Chile, South Africa, Nigeria, Tunisia, Morocco, Germany, United Kingdom (UK), the Netherlands, Spain, Italy, Belgium, Austria, Turkey, Russia, France, Poland, Israel, United Arab Emirates, Qatar, Saudi Arabia, China, Japan, Taiwan, South Korea, Singapore, India, Australia and New Zealand etc.

Enquire for customization in Report @: https://www.advancemarketanalytics.com/enquiry-before-buy/83627-global-rapid-influenza-diagnostic-test-market

Strategic Points Covered in Table of Content of Global Rapid Influenza Diagnostic Test Market:

Chapter 1: Introduction, market driving force product Objective of Study and Research Scope the Rapid Influenza Diagnostic Test market

Chapter 2: Exclusive Summary – the basic information of the Rapid Influenza Diagnostic Test Market.

Chapter 3: Displayingthe Market Dynamics- Drivers, Trends and Challenges of the Rapid Influenza Diagnostic Test

Chapter 4: Presenting the Rapid Influenza Diagnostic Test Market Factor Analysis Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis.

Chapter 5: Displaying market size by Type, End User and Region 2015-2020

Chapter 6: Evaluating the leading manufacturers of the Rapid Influenza Diagnostic Test market which consists of its Competitive Landscape, Peer Group Analysis, BCG Matrix & Company Profile

Chapter 7: To evaluate the market by segments, by countries and by manufacturers with revenue share and sales by key countries (2021-2026).

Chapter 8 & 9: Displaying the Appendix, Methodology and Data Source

Finally, Rapid Influenza Diagnostic Test Market is a valuable source of guidance for individuals and companies in decision framework.

Data Sources & Methodology The primary sources involves the industry experts from the Global Rapid Influenza Diagnostic Test Market including the management organizations, processing organizations, analytics service providers of the industry’s value chain. All primary sources were interviewed to gather and authenticate qualitative & quantitative information and determine the future prospects.

In the extensive primary research process undertaken for this study, the primary sources – Postal Surveys, telephone, Online & Face-to-Face Survey were considered to obtain and verify both qualitative and quantitative aspects of this research study. When it comes to secondary sources Company's Annual reports, press Releases, Websites, Investor Presentation, Conference Call transcripts, Webinar, Journals, Regulators, National Customs and Industry Associations were given primary weight-age.

For Early Buyers | Get Up to 20% Discount on This Premium Report: https://www.advancemarketanalytics.com/request-discount/83627-global-rapid-influenza-diagnostic-test-market

What benefits does AMA research study is going to provide?

Latest industry influencing trends and development scenario

Open up New Markets

To Seize powerful market opportunities

Key decision in planning and to further expand market share

Identify Key Business Segments, Market proposition & Gap Analysis

Assisting in allocating marketing investments

Definitively, this report will give you an unmistakable perspective on every single reality of the market without a need to allude to some other research report or an information source. Our report will give all of you the realities about the past, present, and eventual fate of the concerned Market.

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Southeast Asia.

Contact Us:

Craig Francis (PR & Marketing Manager) AMA Research & Media LLP Unit No. 429, Parsonage Road Edison, NJ New Jersey USA – 08837

[sapanas]

Immunofluorescence Assay Market Growth Prospects, Key Opportunities, Trends, Forecasts, Key Company Profiles And Industry Size, Share Analysis

“The Latest Research Report Global Immunofluorescence Assay Market By 2023 provides information on Market Size, Analysis, Shares, Forecast, Emerging Technologies and Company Profiles for key Industry Participants – Market Research future”

Immunofluorescence Assay Market Overview

The global immunofluorescence assay market is growing pervasively. The market growth attributes to the increase in biological studies in R&D for the detection of biomolecules like glycans, proteins, and small biological and non-biological molecules of various diseases. Also, immunofluorescence assays are primarily used for rapid and sensitive diagnostics of various chronic diseases such as cancer, autoimmune diseases, infectious diseases like HIV, neurological disorders such as Alzheimer's and Parkinson's diseases.

With the intervention of the COVID-19, the immunofluorescence assay industry is witnessing a massive demand across the globe. This is due to the rising usages of immunofluorescence assays in the development of antibodies that can detect sars-Cov-2 in patient samples. According to Market Research Future (MRFR), the global immunofluorescence assay market is projected to register 5.8% CAGR during the analysis period (2017–2023).

Read more news on: https://www.medgadget.com/2020/06/covid-19-impacts-on-the-global-immunofluorescence-assay-market-2020-growth-industry-analysis-size-share-top-company-profile-regional-outlook-swot-analysis.html

Advancements in medical technology, alongside the increasing R&D funding by industry leaders and governments, boost the market growth. Additionally, rising numbers of preclinical research, alongside the rising studies on antibody therapies, advanced drug discoveries, and oncology diseases, accelerate the market growth. Growing collaborations between research institutes and biotechnology companies are expected to drive the growth of the immunofluorescence assay market.

Conversely, the high cost of immunofluorescence assay products such as diagnostic kits is expected to restrict the market growth during the forecast period. Also, factors such as risks of cross contaminations and shortage of skilled labor & weak detection signals are estimated to impede the growth of this market.  Nevertheless, growing advancements in biotechnology & medical science would support the growth of the market, bringing about cost-effective immunofluorescence assay.  

Global Immunofluorescence Assay Market – Segmentation

The Immunofluorescence Assay Market report is segmented into five dynamics;  

By Technique: Primary (Direct) Immunofluorescence Assays and Secondary (Indirect) Immunofluorescence Assays (Salt split technique, Antigenic mapping method, Double Staining method), Micro Immunofluorescence.

By Product Type: Antibodies, Kits & Reagents, Instruments, Microscopes, Imaging Analysis Systems, Labeling dyes, Species Product Type, and others.

By Application: Clinical Research, Clinical Diagnostics, Infectious Diseases, Cancer, Cardiovascular Diseases, Autoimmune Diseases, Neurological Diseases, Research & Development, and others.

By End-User: Biotechnology Companies, Hospitals & Research Institutes, Contract Research Organizations, Diagnostic centers, and others.

By Regions:  Americas, Europe, Asia Pacific, and Rest-of-the-World.

Global Immunofluorescence Assay Market – Regional Analysis

North America dominates the global immunofluorescence assay market. The largest market share attributes to the high prevalence of chronic diseases and rising R&D investments within this region. Also, the rising adoption of advanced systems for early diagnosis of diseases drives the regional market growth. Moreover, the advancement in the development techniques and increasing use of nanotechnology in the development of immunofluorescence assay fostered the growth of the regional market.

The US, among other North American countries, holds the largest share in the regional market. Besides, the presence of vast numbers of biotechnology & pharmaceutical companies impacts the regional market growth positively. The North American immunofluorescence assay market is estimated to retain its leading position throughout the assessment period.

Europe stands second in the immunofluorescence assay market. The market is driven by the increasing prevalence of myriads of chronic diseases such as cancer and the rapidly growing biotechnology sector in Europe. Moreover, substantial R&D investments by the public and private sectors, alongside the increasing R & D in biotechnology, foster the market growth in the region. The European immunofluorescence assay market is projected to create a substantial revenue pocket over the review period.

The immunofluorescence assay market in the Asia Pacific region is growing rapidly. Factors such as the growing patient pool, high incidence of chronic diseases, developing healthcare infrastructure, and increasing R&D activities in the biotechnology sector influence the market in this region. Also, the presence of major market players in China, India, and Japan drive market growth. Rising government initiatives increase the size of the immunofluorescence assay market in the region.

The region witnesses rising developments of immunofluorescence assay products, while several products are under the pipeline, which is carried out under license agreements. The APAC immunofluorescence assay market is expected to grow at an impressive CAGR during the predicted period.

Global Immunofluorescence Assay Market – Competitive Analysis

Highly competitive, the global immunofluorescence assay market appears fragmented due to the presence of several well-established players. To gain a larger competitive advantage, players incorporate strategies such as mergers & acquisitions, collaborations, expansion, and product/technology launch. Top players make huge investments for R&D and clinical trials to develop these assays. Pharmaceutical companies are the largest investors in the immunofluorescence assay market.

Immunofluorescence Assay Market Major Players:

Players leading the global immunofluorescence assay market include Abcam plc., Thermo Fisher Scientific, BioLegend, Inc., Enzo Life Sciences, Inc., Sino Biological Inc., BioTek Instruments, Inc., Bio-Rad Laboratories, Inc., Zyagen Cell Signaling Technology, Inc., PerkinElmer Inc., Becton Dickinson and Company, Merck, Agilent Technologies, TCS Biosciences Ltd, and Maxvision Biosciences Inc., among others.

Immunofluorescence Assay Industry/Innovation/ Related News:

May 29, 2020 --- Rockland Immunochemicals Inc. (the US), a leading global biotechnology company, announced the development of a critical antibody reagent essential to antibody tests used to determine SARS-CoV-2 exposure for patients suspected to have contracted COVID-19. The antibody specifically reacts with the SARS-CoV-2 Nucleocapsid protein present in patient samples and has shown in various independent testing laboratories in regions highly specific and sensitive for SARS-CoV-2.

Rockland manufactures tools for basic, applied, and clinical research in functional genomics, gene therapy, and drug discovery markets. It offers each academic, biopharma, and professional diagnostic thousands of antibodies to provide the right antibody that is the perfect fit for every occasion. The newly developed antibody has proven effective in lateral flow assays (immunochromatography), ELISA, Western blotting, Immunofluorescence microscopy, fluorescence-activated cell sorting, and immunohistochemistry.

Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/immunofluorescence-assay-market-6177

[healthcaremarkettrend]

Immunofluorescence Assay Market 2019 | Key Players are Thermo Fisher, Inova Diagnostics, Bio-Rad, Abcam , PerkinELmer, Danaher

The Report “Immunofluorescence Assay Market by Product (Reagent, Primary & Secondary Antibody, Kit, Imaging Equipment, Immunofluorescence Microscopy), Type (Direct, Indirect), Disease (Cancer, Cardiovascular, Infectious Disease) & End User - Global Forecast to 2023”

The immunofluorescence assay market is expected to reach USD 2.01 Billion by 2023 from USD 1.43 Billion in 2017, at a CAGR of 5.8%. 

The increasing prevalence of chronic diseases, increasing R&D spending, and increasing healthcare spending are the major factors driving the growth of the market.

Immunofluorescence assay is a powerful technique used to analyze the distribution of glycans, proteins, and small biological and non-biological molecules (cells and tissues) using antibodies conjugated with a fluorescent dye, known as fluorophore, which can be visualized using a fluorescence microscope or imaging systems.

Download a FREE Pdf Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=255585571

Research Methodology

Top-down and bottom-up approaches were used to validate the size of the global market and estimate the size of other dependent submarkets. Various secondary sources such as directories, industry journals, databases such as D&B Hoovers, Bloomberg Business, and Factiva, and annual reports of the companies have been used to identify and collect information useful for the study of this market. 

Primary sources such as experts from both supply and demand sides have been interviewed to obtain and validate information as well as to assess dynamics of this immunofluorescence assay industry.

Key Players

The prominent players in the global immunofluorescence assay market are Thermo Fisher (US), Inova Diagnostics (US), Bio-Rad (US), Abcam (UK), PerkinELmer (US), Merck Millipore (US), Cell Signaling Technology (US), MEDIPAN GMBH (Germany), Sino Biological (China), Danaher (US), and Vector Laboratories (US).  Read More

[market-researcher]

Antinuclear Antibody Test Market to Grow by CAGR of ~13% During 2022 – 2031

Research Nester published a report titled “Antinuclear Antibody Test Market: Global Demand Analysis & Opportunity Outlook 2031” which delivers a detailed overview of the global antinuclear antibody test marketin terms of market segmentation by product, disease, technology, end-user, and by region.

Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, and supply and demand risk, along with a detailed discussion of current and future market trends that are associated with the growth of the market.

The global antinuclear antibody test market is projected to grow at a CAGR of ~13% by attaining a noteworthy revenue during the forecast period, i.e., 2022 – 2031. Factors such as, increasing awareness regarding ANA tests and the growing prevalence of autoimmune diseases worldwide are projected to propel the growth of the market over the forecast period. Based on a report published by World Health Organization (WHO), it was stated in 2017, 9 million people were suffering from type 1 diabetes.

Additionally, by technology, the global antinuclear antibody test market is segmented into immunofluorescence, multiplex assay, and ELISA. Out of these sub-segments, the ELISA segment is anticipated to acquire a notable share in the market during the forecast period. ELISA is the shortened form for enzyme-linked immunoassay. The growth of the segment is attributed to its higher utilization in the examination of antibodies in the blood. Furthermore, it is also utilized to monitor the level of therapeutic drugs.

Get a Sample Copy Of This Report With Graphs and Charts: https://www.researchnester.com/sample-request-4133

Furthermore, the global antinuclear antibody test market, by region, is bifurcated into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa region. Out of these regions, the market in the North America region is projected to grow at a noteworthy pace during the forecast period. The growth of the market in the region is attributed to the growing geriatric population and rising cases of autoimmune diseases. According to the report published by American Autoimmune Related Diseases Association (AARDA), it was found that more than 100 types of autoimmune diseases are circulating in the region, meanwhile, 50 million Americans have some sort of autoimmune disease.

The research is global in nature and covers a detailed analysis of the market in North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of the Middle East and Africa). In addition, analysis comprising market size, Y-O-Y growth & opportunity analysis, market players’ competitive study, investment opportunities, demand for future outlook, etc. have also been covered and displayed in the research report.

Rising Cases of Diabetes Globally to Foster the Growth of the Market

A report by World Health Organization (WHO) stated that 422 million people of the global population have diabetes while in 2019, 1.5 million people lost their lives due to diabetes.

Diabetes is referred to as a metabolism disorder that occurs when the blood sugar gets too high or too low. The increased amount of sugar or glucose in the blood can be the major factor to cause health problems, such as, nerve damage, kidney diseases, and heart and eye problems. It requires a scheduled check-up and treatment. Therefore, such factors are anticipated to propel the growth of the market.

However, the lack of skilled medical professionals and errors during the diagnosis procedure is expected to operate as a key restraint to the growth of the global antinuclear antibody test market over the forecast period.

This report also provides the existing competitive scenario of some of the key players in the global antinuclear antibody test market which includes company profiling of F. Hoffmann-La Roche Ltd, ERBA Diagnostics, Inc., Zeus Scientific Inc., Trinity Biotech plc, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Immuno Concepts Inc, Euroimmun Medizinische Labordiagnostika AG, Antibodies Incorporated, and Becton, Dickinson and Company. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials, and recent news and developments. On the whole, the report depicts a detailed overview of the global antinuclear antibody test market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching for possibilities, and other stakeholders to align their market-centric strategies according to the ongoing and expected trends in the future.    

For More Information About This Report Visit– https://www.researchnester.com/sample-request-4133

About Us

Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates, and executives to take wise decisions for their future marketing strategy, expansion and investment, etc. We believe every business can expand to its new horizon, provided the right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decisions in order to avoid future uncertainties.

Contact for more Info:

AJ Daniel

Email: info@researchnester.com

U.S. Phone: +1 646 586 9123

U.K. Phone: +44 203 608 5919

[balrajgis]

Immunofluorescence Assay Market Share to witness steady rise in coming decade | Thermo Fisher Scientific, Inc., Abcam plc, Bio-Rad Laboratories, Inc.

Global Immunofluorescence Assay Market report from Global Insight Services is the single authoritative source of intelligence on Immunofluorescence Assay Market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters’ and PESTLE analysis. Report includes in-depth segmentation and market size data by categories, product types, applications, and geographies. Report also includes comprehensive analysis of key issues, trends and drivers, restraints and challenges, competitive landscape, as well as recent events such as M&A activities in the market.

Immunofluorescence assay (IFA) is an analytical technique used to detect and quantify specific proteins in a sample. Proteins are first isolated from the sample and then incubated with a primary antibody that binds to the protein of interest. The primary antibody is then detected with a secondary antibody conjugated to a fluorescent dye. The fluorescence is then detected and quantified using a microscope or other imaging device.

Download Free Sample of Report – https://www.globalinsightservices.com/request-sample/GIS20553/

Key Trends

There are several key trends in immunofluorescence assay technology. One is the development of more sensitive and specific assays.

This is being driven by the need to detect ever-smaller concentrations of analytes, as well as the need to improve the specificity of detection to ensure that the correct target is being detected.

Another key trend is the miniaturization of immunofluorescence assays.

Key Drivers

The key drivers of the immunofluorescence assay market are the increasing prevalence of chronic diseases, the growing demand for early diagnosis, the rising number of research studies, and the availability of new technologies.

The immunofluorescence assay is a powerful tool for the diagnosis of chronic diseases such as cancer, autoimmune disorders, and infections. The increasing prevalence of these diseases is driving the growth of the immunofluorescence assay market.

Market Segments:

By Product

Reagents

Instruments

By Type

Indirect Immunofluorescence

Direct Immunofluorescence

By Disease

Infectious Diseases

Other Diseases

By End User

Academic & Research Institutes

By Region

North AmericaThe U.S.

Get A Customized Scope to Match Your Need Ask an Expert – https://www.globalinsightservices.com/request-customization/GIS20553/

Key Market Players:

Thermo Fisher Scientific, Inc.

Abcam plc

Bio-Rad Laboratories, Inc.

PerkinElmer Inc.

Merck KGaA

Werfen Company

With Global Insight Services, you receive:

10-year forecast to help you make strategic decisions

In-depth segmentation which can be customized as per your requirements

Free consultation with lead analyst of the report

Excel data pack included with all report purchases

Robust and transparent research methodology

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

Contact Us:

Global Insight Services LLC

16192, Coastal Highway, Lewes DE 19958

E-mail: info@globalinsightservices.com

Phone: +1–833–761–1700

[imrmarket]

Why is it important to diagnose influenza?

Influenza Diagnostics Market Growth and Trends, 2022 by Major Manufacturers

Influenza Diagnostic tests with specificity and high sensitivity are major developments in influenza diagnostics over recent years. Reverse transcription-polymerase chain reaction (RT-PCR) and Nucleic acid labeling detection tests have greatly improved the ability to detect respiratory viruses. Additionally, molecular tests for influenza are mainly focused on the detection of specific known pathogens by NATs. NATs have several advantages over other existing diagnostic tools. They potentially can detect low levels of all-known influenza pathogens in clinical specimens, do not depend on the viability of the target microbe, and can provide results within a clinically relevant time frame.

Influenza Diagnostics Market size is projected to reach USD 1.3 billion in 2027 from an estimated USD 0.86 billion in 2021, growing at a CAGR of 7.4% globally.

Market analysis, sizing, and forecast of the influenza diagnostics market are covered in the report. The country-level assessment of the market and associated forecasts are explained in the influenza diagnostics market report. The expansion of the influenza diagnostic controlling market dynamics intelligence that includes, market drivers, opportunities, supply chain, restraints, trends, value chain analysis, and Porter’s five forces are studied by MRFR analysts. Patent analysis outlook, Technology trends, and regulatory landscape of the market is detailed in the report to help investors acquire an in-depth understanding of the market and associated activities.

Download a Free Sample Copy of the Market Report: - 

https://introspectivemarketresearch.com/request/15919

The Major Players In The Influenza Diagnostics Market Include:

·         Danaher Corporation (US)

·         Siemens Healthineers (Germany)

·         Thermo Fisher Scientific Inc. (US)

·         F. Hoffmann-LA Roche AG (Switzerland)

·         Abbott Laboratories Inc. (Us)

·         Hologic Inc. (US)

·         bioMérieux SA (France)

·         Quidel Corporation (US)

·         Becton

·         Dickinson and Company (US)

·         Meridian Bioscience (US)

·         GenMark Diagnostics Inc. (US)

·         Luminex Corporation (US)

·         Tecan Trading AG (Switzerland)

Market has segmented the global Influenza Diagnostics market on the basis of type, application, and region:

The Influenza Diagnostics market is segmented by type and application. Growth between segments over the period 2022-2028 provides accurate calculations and forecasts of revenue by type and application in terms of volume and value. This analysis can help you expand your business by targeting eligible niches.

By Type:

·         Traditional Rapid Influenza Detection Tests Viral Culture Immunoassay Kits Immunofluorescence Assays And Serological Testing (Rapid Influenza Detection Tests

·         Viral Culture

·         Immunoassay Kits

·         Immunofluorescence Assays

·         And Serological Testing)

·         Rapid Influenza Detection Tests

·         Viral Culture

·         Immunoassay Kits

 By End Users:

·         Clinical Laboratories

·         Hospitals

·         Research And Academic Institutes

·         And Diagnostic Laboratories

 By Regional Outlook (Revenue, USD Billion, 2017 – 2028)

North America (U.S., Canada,     Mexico)

Europe (Germany, U.K., France,     Italy, Russia, Spain, Rest of Europe)

Asia-Pacific (China, India,     Japan, Southeast Asia, Rest of APAC)

Middle East & Africa (GCC     Countries, South Africa, Rest of MEA)

South America (Brazil,     Argentina, Rest of South America)

Get Discount on This Report @: 

https://introspectivemarketresearch.com/discount/15919

Covid-19 Impact and Recovery Analysis on Industry:

The COVID-19 pandemic has had devastating effects on several industry verticals globally. To constrain the number of cases and slow the coronavirus spread, various public health guidelines were implemented in different countries across the globe. COVID-19 protocols ranging from declaring national emergency states, enforcing stay-at-home orders, closing nonessential business operations and schools, banning public gatherings, imposing curfews, distributing digital passes, and allowing police to restrict citizen movements within a country, as well as closing international borders. With the growing vaccination rate, governments are uplifting the protocols to give a boost to the stagnant economy. Like other industries, Influenza Diagnostics Market have experienced slowdown the growth, however market is expected bounce back as restrictions are being lifted up by governments across the globe. 

Key Points Covered in Influenza Diagnostics Industry Survey:

Market Estimates and Forecasts     (2022-2028)

Key Drivers and Restraints     Shaping Market Growth

Segment-wise, Country-wise and     Region-wise Analysis

Competition Mapping and     Benchmarking

Market Share Analysis

COVID-19 Impact on Demand for     Influenza Diagnostics and How to Navigate

Recommendation on Key Winning     Strategies

If You Have Any Query of Influenza Diagnostics Market Report, Visit.@

https://www.introspectivemarketresearch.com/inquiry/15919

[sapanas]

Immunofluorescence Assay Market 2020: Key Findings, Regional Study, Global Segments, Emerging Technologies, Business Trends and Future Prospects

The report gives detail analysis of the “Immunofluorescence Assay Market” structure along with forecast, market size & share, different segments and developing trends of the industry.

Immunofluorescence Assay Market Overview

The global immunofluorescence assay market is expected to grow at a 5.8% CAGR over the forecast period from 2018 to 2023, according to the latest research report from Market Research Future (MRFR). The report presents a detailed analysis of the global liquid handling system market by providing readers with a comprehensive overview of the market’s historical trajectory. The leading drivers and restraints affecting the global liquid handling system market are assessed in detail in the report. The historical impact of these drivers and restraints is analyzed in context of the current impact of these factors and projections are made for the likely impact of these drivers and restraints over the forecast period. Various components of the global liquid handling system market are also studied in the report and projections are made for the growth trajectory of each distinct component.

Read more news on: https://www.medgadget.com/2020/06/covid-19-impacts-on-the-global-immunofluorescence-assay-market-2020-growth-industry-analysis-size-share-top-company-profile-regional-outlook-swot-analysis.html

The various segments and sub-segments within the global liquid handling system market are studied in detail in the report. The study also makes a detailed analysis of the major players operating in the global liquid handling system market and provides a detailed look at the various competitive strategies employed by players in the global liquid handling system market. Likely future conditions with respect to the competitive landscape of the market are also explained in detail in the report.

Immunofluorescence assays are widely used to diagnose diseases such as cancer, HIV, Alzheimer’s, and autoimmune diseases. Immunofluorescence assays are especially used in the detection of autoimmune diseases. The growing prevalence of autoimmune diseases is thus likely to be a major driver for the global immunofluorescence assay market over the forecast period. According to the National Institutes of Health (NIH), in 2012, about 23.5 Americans suffered from autoimmune diseases, making the category more prevalence than cancer. This is likely to be a major driver for the global immunofluorescence assay market over the forecast period. The growing prevalence of cancer is also likely to be a major driver for the global immunofluorescence assay market. Cancer has taken many lives around the world in recent years, with early diagnosis emerging as the best option for controlling the disease. This has the potential to drive the global immunofluorescence assay market at a strong growth rate over the forecast period.

Immunofluorescence Assay Market Competitive Analysis:

Leading players in the global immunofluorescence assay market include Maxvision Biosciences Inc., TCS Biosciences Ltd., Agilent Technologies, Merck, Becton Dickinson and Company, PerkinElmer Inc., Cell Signaling Technology Inc., Zyagen, Bio-Rad Laboratories Inc., BioTek Instruments Inc., Sino Biological Inc., Enzo Life Sciences Inc., BioLegend Inc., Thermo Fisher Scientific, and Abcam plc.

In November 2019, Ultivue announced the addition of a T-reg and MDSC kit to its UltiMapper multiplex immunofluorescence kit portfolio.

Immunofluorescence Assay Market Segmentation:

The global immunofluorescence assay market is segmented on the basis of technique, product type, application, end use, and region.

By technique, the global immunofluorescence assay market is segmented into primary (direct) immunofluorescence assays, secondary (indirect) immunofluorescence assays, and micro immunofluorescence. The secondary immunofluorescence assay segment is further sub-segmented into salt split technique, antigenic mapping method, and double staining method.

By product type, the global immunofluorescence assay market is segmented into antibodies, kits and reagents, instruments, microscopes, imaging analysis systems, labeling dyes, and species product type.

By application, the global immunofluorescence assay market is segmented into clinical research, clinical diagnostics, infectious diseases, cancer, cardiovascular diseases, autoimmune diseases, neurological diseases, and research and development.

By end use, the global immunofluorescence assay market is segmented into biotechnology companies, hospitals and research institutes, contract research organizations, and diagnostic centers.

Immunofluorescence Assay Market Regional Analysis:

North America is likely to dominate the global immunofluorescence assay market, followed by Europe and Asia Pacific. North America is the leading regional market for immunofluorescence assay due to the growing prevalence of chronic diseases such as cancer and autoimmune diseases, and the growing awareness about the same. The strong presence of leading market players and widespread adoption of advanced immunofluorescence assay techniques in North America is also likely to be a major driver for the immunofluorescence assay market in North America. Asia Pacific is likely to be the fastest growing immunofluorescence assay market over the forecast period.

Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/immunofluorescence-assay-market-6177